Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma
Abstract Non-alcoholic fatty liver disease (NAFLD) is the most common chronic hepatic pathology in Western countries. It encompasses a spectrum of conditions ranging from simple steatosis to more severe and progressive non-alcoholic steatohepatitis (NASH) that can lead to hepatocellular carcinoma (H...
Guardado en:
Autores principales: | Sophie Jacques, Arash Arjomand, Hélène Perée, Patrick Collins, Alice Mayer, Arnaud Lavergne, Marie Wéry, Myriam Mni, Alexandre Hego, Virginie Thuillier, Guillaume Becker, Mohamed Ali Bahri, Alain Plenevaux, Emmanuel Di Valentin, Cécile Oury, Michel Moutschen, Philippe Delvenne, Nicolas Paquot, Souad Rahmouni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/10538d19699b48e291e33a6afd964897 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Statins in Non-alcoholic Steatohepatitis
por: Jose D. Torres-Peña, et al.
Publicado: (2021) -
Association between Equol Production Status and Nonalcoholic Steatohepatitis
por: Takemi Akahane, et al.
Publicado: (2021) -
Cathepsin D regulates lipid metabolism in murine steatohepatitis
por: Tom Houben, et al.
Publicado: (2017) -
New approach to determine the healthy immune variations by combining clustering methods
por: Claire Liefferinckx, et al.
Publicado: (2021) -
Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway.
por: Farah Ketroussi, et al.
Publicado: (2011)